Company: FRFXF
Filing Date: 2025-10-09
Form Type: F-10/A
Source: 0001104659-25-098335
Chunk: 110

Company: FAIRFAX FINANCIAL HOLDINGS LTD/ CAN
Filing Date: 2025-10-09
Form: F-10/A
Chunk 110
---
 to enhanced supervisory monitoring by the BMA or any relevant supervisory authority; and

(v)

Whether the BMA is the group-wide supervisor of the insurance group.

Where the BMA has determined that a (re)insurer is in scope of the Recovery Plan Rules, the BMA will provide written notice of such determination to the (re)insurer.

In determining the scope and requirements of a recovery plan to be prepared by a (re)insurer, the BMA will take into consideration the class of registration, size or market share, external and internal interconnectedness, complexity, business model, risk profile, substitutability and cross-border activities of the (re)insurer.

<div align='center'>66</div>

TABLE OF CONTENTS

### DESCRIPTION OF THE NOTES
As used under this heading “Description of the Notes,” the terms “Fairfax,” “Company,” “we,” “us” and “our” refer only to Fairfax Financial Holdings Limited, and not its subsidiaries. The Company issued each series of the Initial Notes under an indenture, dated as of December 1, 1993, as supplemented and amended by the first supplemental indenture dated May 9, 2011, the Third Supplemental Indenture and the sixth supplemental indenture dated May 20, 2025 (collectively, the “

#### Indenture
”), among the Company, The Bank of New York Mellon, as successor U.S. trustee (the “

#### United States trustee
” or the “

#### trustee
”), and Computershare Advantage Trust of Canada, as successor Canadian trustee (the “

#### Canadian trustee
” and, together with the United States trustee, the “

#### trustees
”) in private transactions that were not subject to the registration requirements of the Securities Act or the requirement to qualify the Initial Notes by prospectus or otherwise under Canadian securities legislation. The Company has agreed to offer to exchange the Initial Notes of each series for new issues of substantially identical series of debt securities (as previously defined as the Exchange Notes) registered under the Securities Act. The issuance of the Exchange Notes in this offering (together with any Initial Notes that are not tendered and accepted for purchase) will be limited to (i) $500 million in respect of the 2035 Notes and (ii) $400 million in respect of the 2055 Notes. The Exchange Notes, together with any Initial Notes that remain outstanding after the closing of the Exchange Offers, are referred to herein as